Safety and efficacy of an intraocular Fresnel prism intraocular lens in patients with advanced macular disease: Initial clinical experience

Abstract

Dr. Claoué has a financial interest in the patent controlling the Fresnel prism IOL. Dr. Potgieter has no financial or proprietary interest in any material or method mentioned.